Lunai Bioworks LNAI
NASDAQ LNAI
$2.15 -0.05 (-2.05%)
As of: Aug 21, 2026 · 3:59 PM EDT

Lunai Bioworks (LNAI) FCF Margin Growth (3y) (2016)

Lunai Bioworks (LNAI) FCF Margin Growth (3y) (2016) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin Growth (3y) (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -1,272.00
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -2,228.00
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -5,426.00
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 9,545.00
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 4,612.00
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 1,850.00
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 14,060.00
9 Royalty Pharma 27.27 Bn 26.43 Bn - -3,088.00
10 Lunai Bioworks 6.87 Mn 3.72 Mn 20,942.00 -

Historic Data

Download Data
DateValue
Jun 30, 2016 110.66 Mn